Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma
Clinical trial NCT07547592 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07547592
- Sponsor
- Yonsei University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-11-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.